IRINA SHULGINA: Open Payments
NPI 1376634774 · CARMICHAEL, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,165 in 156 payments from 32 companies in 2025. Trend: 2023 $797 · 2024 $2,746 · 2025 $3,165
Food & beverage: $3,165
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $604 |
| Ardelyx, Inc. | 9 | $311 |
| Aimmune Therapeutics, Inc. | 7 | $310 |
| Vanda Pharmaceuticals Inc. | 14 | $283 |
| Biogen, Inc. | 18 | $179 |
| GlaxoSmithKline, LLC. | 8 | $176 |
| Madrigal Pharmaceuticals | 2 | $170 |
| Neurocrine BioSciences, Inc. | 5 | $162 |
| Novo Nordisk Inc | 7 | $160 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $126 |
Products named: LINZESS, IBSRELA, ZENPEP, TRELEGY ELLIPTA, REZDIFFRA, INGREZZA, CREON, Kerendia.
Industry payments across CA — which companies pay providers there.
